Neuroone Medical Technologies (NMTC) Net Shares Issued and Repurchased (2018 - 2026)

Neuroone Medical Technologies (NMTC) has reported Net Shares Issued and Repurchased for 7 consecutive years, with $29027.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Shares Issued and Repurchased fell 94.7% year-over-year to $29027.0; the trailing twelve-month figure through Jun 2026 stood at $29027.0 (down 94.7% YoY), and the FY2025 full-year result was $3.3 million, up 172.22% from the prior year.
• Net Shares Issued and Repurchased fell to $29027.0 in Q2 2026 per NMTC's latest filing, from $83334.0 in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $3.3 million in Q3 2025 and bottomed at $4806.0 in Q4 2025.
• Historically, Net Shares Issued and Repurchased has averaged $539492.6 across 5 years, with a median of $118012.0 in 2022.
• The sharpest annual moves came in 2023 and 2026: Net Shares Issued and Repurchased jumped 1474.19% in 2023, then plunged 94.7% in 2026.
• Over 5 years, Net Shares Issued and Repurchased stood at $73731.0 in 2022, then surged by 1474.19% to $1.2 million in 2023, then climbed by 5.6% to $1.2 million in 2024, then plunged by 99.61% to $4806.0 in 2025, then surged by 503.97% to $29027.0 in 2026.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $29027.0, $83334.0, and $4806.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.